Physiomics inks further contracts with Bicycle Therapeutics
21st May 2021 09:53
(Sharecast News) - Oncology drug development consultancy Physiomics said on Friday that it has been awarded two further contracts by existing client Bicycle Therapeutics.
Read morePhysiomics secures additional contract with Merck
14th May 2021 08:27
(Sharecast News) - Drug development consultancy Physiomics has been awarded a further contract with a leading science and technology company Merck.
Read morePhysiomics secures contract with Numab Therapeutics
11th May 2021 10:46
(Sharecast News) - Consultancy firm Physiomics said on Tuesday that it has been awarded a first contract with new client Numab Therapeutics.
Read morePhysiomics FY income likely to fall short of market expectations
10th May 2021 08:40
(Sharecast News) - Technology-based solutions provider Physiomics said on Monday that total income for the financial year ending 30 June was likely to be below market expectations due to both Covid-19 related project delays and an increased focus on longer-term value-generating activities.
Read morePhysiomics and ValiRx enter new collaboration deal
15th Feb 2021 16:04
(Sharecast News) - Oncology consulting company Physiomics has entered into a new agreement with clinical-stage drug development company ValiRx, it announced on Monday, superseding the agreement between the two companies, which was announced in September 2011.
Read morePhysiomics gets initial 2021 commitment from client Merck
17th Dec 2020 13:59
(Sharecast News) - Oncology consultancy Physiomics announced on Thursday that its existing client, Merck, has committed to an initial tranche of projects for 2021 with a total value of £0.27m.
Read morePhysiomics awarded further contracts with Bicycle Therapeutics and Merck
16th Oct 2020 09:30
(Sharecast News) - Oncology consultancy Physiomics has been awarded further contracts of an undisclosed value for projects with existing clients Bicycle Therapeutics and Merck.
Read morePhysiomics wins contract with Japan-based Astellas Pharma
31st Jul 2020 12:08
(Sharecast News) - Oncology consultancy Physiomics announced on Friday that it has been awarded a contract by a new client, Japan-based global pharmaceutical company Astellas Pharma.
Read morePhysiomics raises £829,000 to fund further development
27th May 2020 10:30
(Sharecast News) - Oncology consultancy Physiomics has raised roughly £829,000 through a share issue to finance further development.
Read morePhysiomics receives 'Connect' funding award from NIHR
10th Mar 2020 11:39
(Sharecast News) - Oncology consulting company Physiomics has received a 'Connect' award from the National Institute for Health Research's (NIHR) 'Invention for Innovation' (i4i) programme, for the continued development of its tool for use in the personalised treatment of cancer.
Read morePhysiomics H1 revenues on the rise
3rd Mar 2020 10:19
(Sharecast News) - Oncology consultancy Physiomics said on Tuesday that interim losses had widened despite posting an improvement in revenues.
Read morePhysiomics scores further project agreement with CellCentric
23rd Dec 2019 08:33
(Sharecast News) - Oncology consultancy business Physiomics has been awarded a further project agreement with British biotech outfit CellCentric.
Read morePhysiomics surges amid deepened Merck collaboration
20th Dec 2019 11:27
(Sharecast News) - Shares of Physiomics leapt on Friday after it signed up to a £250,000 tranche of projects with pharmaceutical giant Merck and said trading was in line with expectations.
Read morePhysiomics wins immune-oncology contract from Bicycle Therapeutics
28th Jun 2019 10:56
(Sharecast News) - Cancer treatment technology provider Physiomics has been awarded a contract by Nasdaq-listed Bicycle Therapeutics, it announced on Friday.
Read morePhysiomics narrows interim loss as revenue leaps
21st Feb 2019 11:51
(Sharecast News) - Physiomics on Thursday reported a narrowed interim loss after the cancer monitoring technology provider more than doubled its revenue over the period.
Read more